Accessing the accelerated approval pathway for rare disease therapeutics. [electronic resource]
- Nature biotechnology Apr 2016
- 380-3 p. digital
Publication Type: Journal Article
1546-1696
10.1038/nbt.3530 doi
Biomarkers--analysis Drug Approval--legislation & jurisprudence Humans Rare Diseases--diagnosis United States United States Food and Drug Administration